Daniel Castellano, MD
Hospital 12 de Octubre
2
2
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Changting Meng, MD
Seagen Inc.
Shared therapeutic areas:
Xavier García del Muro, M.D.
Instituto Catalán de Oncología L'Hospitalet
Shared therapeutic areas:
Professor Robert Huddart
Royal Marsden NHS Foundation Trust
Shared therapeutic areas:
Andrea Necchi, Dr.
IRCCS San Raffaele Hospital
Shared therapeutic areas:
Kimberly Rieger-Christ, PhD
Lahey Clinic, Inc.
Shared therapeutic areas:
Douglas S Scherr, MD
Weill Cornell Medicine - New York Presbyterian Hospital
Shared therapeutic areas:
Jason Lukas, MD, PhD
Seagen Inc.
Shared therapeutic areas:
Anish Thomas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Srikala Sridhar
Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario Canada
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)
Niraparib in Combination with Cabozantinib (XL184) in Patients with Advanced Urothelial Cancer (NICARAGUA)
All 2 trials loaded